Full-Life Technology Europe

Full-Life Technology Europe, a subsidiary of Full-Life Technology, has recently obtained a radiation safety license ("RadSafe license") applicable to Class IIA facilities issued by the Belgian Federal Agency for Nuclear Control ("FANC"). This license authorizes the construction and operation of this key facility for the production of therapeutic radioisotopes. The facility will not only support preclinical and clinical research for internal pipeline drug candidates by providing the necessary Ac-225 radioisotopes, but will also promote the commercialization of Ac-225 labeled compounds, helping to meet the growing global demand for Ac-225 radiopharmaceuticals.